Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

A total of 170 febrile episodes in neutropenic patients with cancer were randomly assigned to be treated with piperacillin-amikacin or ceftazidime-amikacin. The overall response rates were similar in both groups (68 and 65%, respectively). Response rates for clinically or microbiologically documente...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Feliu, J, Artal, A, González Barón, M, Berrocal, A, Chacón, I, García de Paredes, M L, Espinosa, E, Ordóñez, A, Zamora, P, Montero, J M
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1992
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245551/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1482151/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.12.2816
Oznake:	Označite Brez oznak, prvi označite!